Your patient has become unusually angry and demanding after his third radiation treatment.
As the nurse, you recognize that:

Choice A rationale

Suggesting the client avoid eating until hungry is generally not the best intervention for chemotherapy-induced nausea and loss of appetite. Prolonged fasting can worsen malnutrition, lead to energy deficits, and potentially exacerbate nausea due to an empty stomach, hindering recovery and treatment tolerance.

Choice B rationale

Encouraging the client to eat three large meals per day is often counterproductive during chemotherapy when nausea and appetite loss are prevalent. Large meals can overwhelm the digestive system, increase feelings of fullness, and trigger or worsen nausea and vomiting, leading to reduced intake.

Choice C rationale

Advising the client to increase their intake of fatty foods is generally not recommended for chemotherapy-induced nausea. Fatty foods are more difficult to digest, can delay gastric emptying, and are more likely to exacerbate nausea, bloating, and discomfort in a compromised digestive system.

Choice D rationale

Offering small, frequent meals that are easy to digest is the most effective intervention. This approach minimizes gastric distention, reduces the likelihood of triggering nausea, and allows for consistent nutrient intake. Easily digestible foods like crackers, toast, and clear broths are preferred, maintaining hydration.

Choice A rationale

Weight loss over several weeks, while a concerning symptom in a cancer patient, is not the most specific or immediate finding indicative of superior vena cava syndrome (SVCS). Weight loss is a general symptom of malignancy (cancer cachexia) due to increased metabolic demands, catabolism, and reduced caloric intake. SVCS involves specific obstruction of venous return to the heart, leading to distinct signs and symptoms related to impaired blood flow from the head, neck, and upper extremities.

Choice B rationale

Facial swelling and edema is the most concerning and classic finding indicative of superior vena cava syndrome. Obstruction of the superior vena cava, often by an extrinsic tumor compression (e.g., lung cancer, lymphoma), impairs venous drainage from the head, neck, and upper extremities. This leads to increased hydrostatic pressure in these areas, resulting in visible facial edema, periorbital edema, and swelling of the neck and arms.

Choice C rationale

Increased appetite is generally not associated with superior vena cava syndrome or advanced cancer. Patients with cancer, especially those with advanced disease or undergoing treatment, frequently experience anorexia, early satiety, and altered taste, leading to decreased appetite and weight loss. SVCS itself does not directly influence appetite regulation, though the underlying malignancy might contribute to systemic symptoms that affect appetite negatively.

Choice D rationale

Mild nausea and vomiting, while possible symptoms in a cancer patient due to various factors (e.g., chemotherapy, pain medication, hypercalcemia), are not specifically indicative of superior vena cava syndrome. SVCS is characterized by signs and symptoms related to venous congestion in the upper body. Nausea and vomiting are non-specific gastrointestinal symptoms and do not directly arise from the pathophysiology of superior vena cava obstruction.